Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein

Cancer Res. 1997 Aug 15;57(16):3365-9.

Abstract

Incubation in vitro of recombinant wild-type murine p53 protein with S-nitroso-N-acetyl-DL-penicillamine [a nitric oxide (NO)-releasing compound] has resulted in a change of p53 conformation and also in a significant decrease of its specific DNA binding activity. Similarly, upon treatment with S-nitroso-N-acetyl-DL-penicillamine (2-5 mM) or S-nitroso-glutathione (1-2 mM), human breast cancer cells (MCF-7), which express wild-type p53, rapidly accumulated p53 protein in the nuclei. This p53 protein, however, possessed a significantly decreased activity of specific DNA binding. On the other hand, lower concentrations of NO donors (0.25-0.5 mM) stimulated p53 accumulation as well as its DNA binding activity. These results suggest that excess NO produced in inflamed tissues could play a role in carcinogenesis by impairing the tumor suppressor function of p53.

MeSH terms

  • Breast Neoplasms / metabolism
  • Carcinoma, Hepatocellular / metabolism
  • DNA, Neoplasm / metabolism*
  • Glutathione / analogs & derivatives*
  • Glutathione / pharmacology
  • Humans
  • Liver Neoplasms / metabolism
  • Nitric Oxide / physiology*
  • Nitroso Compounds / pharmacology*
  • Penicillamine / analogs & derivatives*
  • Penicillamine / pharmacology
  • S-Nitroso-N-Acetylpenicillamine
  • S-Nitrosoglutathione
  • Tumor Cells, Cultured
  • Tumor Suppressor Protein p53 / chemistry
  • Tumor Suppressor Protein p53 / drug effects*
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • DNA, Neoplasm
  • Nitroso Compounds
  • Tumor Suppressor Protein p53
  • Nitric Oxide
  • S-Nitrosoglutathione
  • S-Nitroso-N-Acetylpenicillamine
  • Glutathione
  • Penicillamine